Novel anti-inflammatory target of geniposide: Inhibiting Itgβ1/Ras-Erk1/2 signal pathway via the miRNA-124a in rheumatoid arthritis synovial fibroblasts
- 1 December 2018
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 65, 284-294
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81473400)
This publication has 44 references indexed in Scilit:
- MicroRNA in immunity and autoimmunityJournal of Molecular Medicine, 2013
- MicroRNA-124a Is Epigenetically Regulated and Acts as a Tumor Suppressor by Controlling Multiple Targets in Uveal MelanomaInvestigative Ophthalmology & Visual Science, 2013
- Impact of microRNAs on the understanding and treatment of rheumatoid arthritisCurrent Opinion in Rheumatology, 2013
- The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISCNature Structural & Molecular Biology, 2012
- Geniposide, an Iridoid Glucoside Derived fromGardenia jasminoides, Protects against Lipopolysaccharide-Induced Acute Lung Injury in MicePlanta Medica, 2012
- Role of NF-κB in the skeletonCell Research, 2010
- miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinomaCarcinogenesis, 2009
- MicroRNA‐124a is a key regulator of proliferation and monocyte chemoattractant protein 1 secretion in fibroblast‐like synoviocytes from patients with rheumatoid arthritisArthritis & Rheumatism, 2009
- Analysis of Basement Membrane Structure and Inflammation During the Development of Esophageal Squamous Cell Carcinoma in the Chinese Chaoshan High Risk RegionCancer Investigation, 2008
- The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transitionOncogene, 2007